Pharmafile Logo

Wilmington Healthcare appoints new consultants

October 17, 2019 |  

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants – Roger Tomlins and Sarah Shield.

Wilmington Healthcare appoints new consultants

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants – Roger Tomlins and Sarah Shield.

In their new roles, Roger and Sarah will help healthcare business leaders to better understand the NHS’s evolving needs and work in strategic partnership with it, as it continues to implement the Long-term Plan and the delivery of sustainable, high value healthcare.

Roger has worked in healthcare for over 16 years, in both the pharmaceutical industry and the NHS. He has joined Wilmington Healthcare from Bristol-Myers Squibb, where he was Senior Regional Access Manager and led new customer- focused initiatives for the company in cardiology and oncology.

Prior to that, he worked for Pfizer Essential Health as a Clinical Effectiveness Consultant. His NHS experience includes working for the Royal Berkshire NHS Foundation Trust as General/Operations Manager for four years, where he led key hospital directorates, including surgery and medicine.

Sarah has worked in the pharmaceutical industry for 14 years and has wide experience of providing consultancy on market access, strategic partnerships, clinical policy development and government affairs.

Before joining Wilmington Healthcare, Sarah was National Policy and Partnership Lead for AstraZeneca UK’s cardiovascular and renal franchise, and provided strategic insight on NHS policies, commissioning and reimbursement pathways.

Other posts that Sarah has held at AstraZeneca, include National NHS Relations Lead, Cardiovascular & Oncology.  Prior to that, she worked for GlaxoSmithKline for four years in roles that included Therapy Specialist for its allergy portfolio.

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in diverse roles within the healthcare sector, Roger and Sarah bring a wealth of knowledge and experience to their new posts.

“They are perfectly placed to help our clients keep pace with the scale and speed of change within the NHS and create compelling propositions. They will be a great asset to our consultancy team, and we’re delighted to be working with them.”

- PMLiVE

- PMLiVE

Ends

Notes to Editors

For more information, please contact: Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com

About Wilmington Healthcare and Wilmington plc

Wilmington Healthcare within the UK, incorporates HSJ, Interactive Medica and OnMedica. A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.

Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Unique forum will unite NHS and industry to drive innovation

HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

Wilmington Healthcare survey finds many doctors fear the NHS will fall victim to another ransomware attack

Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider...

Innovative NHS suppliers scoop HSJ Partnership Awards

Winners include pharma, medtech, healthcare consultants and IT specialists. Innovative pharma and medtech companies have been honoured in an awards scheme run by Health Service Journal (HSJ), the news and...

Managing local population needs is key for the NHS

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma

Large-scale NHS commissioning models require new partnership approach from pharma

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working

Leading NHS suppliers highlighted in shortlist for new HSJ awards

The finalists for the first HSJ Healthcare Partnership Awards have been announced. The awards serve to recognise and celebrate those suppliers who work in partnerships with the NHS to drive...

Shining a light on the true cost of patient care

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS

How can pharma engage with the top performing STPs?

The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...